Transgenic zebrafish reveal tissue-specific differences in estrogen signaling in response to environmental water samples

Environmental Health Perspectives

Volumn 122, Issue 4, 2014, Pages 356-362

  Gorelick, Daniel A ^a   Iwanowicz, Luke R ^b   Hung, Alice L ^a   Blazer, Vicki S ^b   Halpern, Marnie E ^a  

^a GEOPHYSICAL LABORATORY   (United States)

^b U S GEOLOGICAL SURVEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GREEN FLUORESCENT PROTEIN; MORPHOLINO OLIGONUCLEOTIDE; WATER; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART EDEMA; HEART VALVE; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SPECIFICITY; ZEBRA FISH; ANIMAL; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; TOXICITY; TRANSGENIC ANIMAL; UTERUS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ENDOCRINE DISRUPTORS; ESTROGENS; FEMALE; GREEN FLUORESCENT PROTEINS; RECEPTORS, ESTROGEN; UTERUS; ZEBRAFISH;

EID: 84897396871     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1307329     Document Type: Article

References (40)

1. Alvarez DA. 2010. Guidelines for the Use of the Semipermeable Membrane Device (SPMD) and the Polar Organic Chemical Integrative Sampler (POCIS) in Environmental Monitoring Studies. Techniques and Methods 1-D4. Reston, VA:U.S. Geological Survey. Available: http://pubs.usgs.gov/tm/tm1d4/pdf/tm1d4.pdf [accessed 19 February 2014].
2. Alvarez DA, Cranor WL, Perkins SD, Schroeder VL, Iwanowicz LR, Clark RC, et al. 2009. Reproductive health of bass in the Potomac, USA, drainage: part 2. Seasonal occurrence of persistent and emerging organic contaminants. Environ Toxicol Chem 28(5):1084-1095.
3. Alvarez DA, Petty JD, Huckins JN, Jones-Lepp TL, Getting DT, Goddard JP, Manahan SE. 2004. Development of a passive, in situ, integrative sampler for hydrophilic organic contaminants in aquatic environments. Environ Toxicol Chem 23:1640-1648.
4. Balsiger HA, de la Torre R, Lee WY, Cox MB. 2010. A four-hour yeast bioassay for the direct measure of estrogenic activity in wastewater without sample extraction, concentration, or sterilization. Sci Total Environ 408(6):1422-1429.
5. Bergamasco AM, Eldridge M, Sanseverino J, Sodre FF, Montagner CC, Pescara IC, et al. 2011. Bioluminescent yeast estrogen assay (BLYES) as a sensitive tool to monitor surface and drinking water for estrogenicity. J Environ Monit 13(11):3288-3293.
6. Bertrand S, Thisse B, Tavares R, Sachs L, Chaumot A, Bardet PL, et al. 2007. Unexpected novel relational links uncovered by extensive developmental profiling of nuclear receptor expression. PLoS Genetics 3(11):e188; doi:10.1371/journal.pgen.0030188.
7. Blazer VS, Iwanowicz LR, Starliper CE, Iwanowicz DD, Barbash P, Hedrick JD, et al. 2010. Mortality of centrarchid fishes in the Potomac drainage: survey results and overview of potential contributing factors. J Aquat Anim Health 22:190-218.
8. Brion F, Le Page Y, Piccini B, Cardoso O, Tong SK, Chung BC, et al. 2012. Screening estrogenic activities of chemicals or mixtures in vivo using transgenic (cyp19a1b-GFP) zebrafish embryos. PLoS ONE 7(5):e36069; doi:10.1371/journal.pone.0036069.
9. Ciana P, Raviscioni M, Mussi P, Vegeto E, Que I, Parker MG, et al. 2003. In vivo imaging of transcriptionally active estrogen receptors. Nat Med 9(1):82-86.
10. Ciparis S, Iwanowicz LR, Voshell JR. 2012. Effects of watershed densities of animal feeding operations on nutrient concentrations and estrogenic activity in agricultural streams. Sci Total Environ 414:268-276.
11. Compton DR, Sheng S, Carlson KE, Rebacz NA, Lee IY, Katzenellenbogen BS, et al. 2004. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor β antagonist activity. J Med Chem 47(24):5872-5893.
12. Cosnefroy A, Brion F, Maillot-Maréchal E, Porcher JM, Pakdel F, Balaguer P, et al. 2012. Selective activation of zebrafish estrogen receptor subtypes by chemicals by using stable reporter gene assay developed in a zebrafish liver cell line. Toxicol Sci 125(2):439-449.
13. Deroo BJ, Korach KS. 2006. Estrogen receptors and human disease. J Clin Invest 116(3):561-570.
14. Gorelick DA, Halpern ME. 2011. Visualization of estrogen receptor transcriptional activation in zebrafish. Endocrinology 152(7):2690-2703.
15. Gruber CJ, Gruber DM, Gruber IM, Wieser F, Huber JC. 2004. Anatomy of the estrogen response element. Trends Endocrinol Metab 15(2):73-78.
16. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, et al. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138(3):863-870.
17. Kurauchi K, Nakaguchi Y, Tsutsumi M, Hori H, Kurihara R, Hashimoto S, et al. 2005. In vivo visual reporter system for detection of estrogen-like substances by transgenic medaka. Environ Sci Technol 39(8):2762-2768.
18. Lauter G, Söll I, Hauptmann G. 2011. Multicolor fluorescent in situ hybridization to define abutting and overlapping gene expression in the embryonic zebrafish brain. Neural Dev 6:10; doi:10.1186/1749-8104-6-10.
19. Lee O, Takesono A, Tada M, Tyler CR, Kudoh T. 2012. Biosensor zebrafish provide new insights into potential health effects of environmental estrogens. Environ Health Perspect 120(7):990-996; doi:10.1289/ehp.1104433.
20. Legler J, Broekhof JLM, Brouwer A, Lanser PH, Murk AJ, van der Saag PT, et al. 2000. A novel in vivo bioassay for (xeno-)estrogens using transgenic zebrafish. Environ Sci Technol 34(20):4439-4444.
21. Legler J, van den Brink CE, Brouwer A, Murk AJ, van der Saag PT, Vethaak AD, et al. 1999. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci 48(1):55-66.
22. Leskinen P, Michelini E, Picard D, Karp M, Virta M. 2005. Bioluminescent yeast assays for detecting estrogenic and androgenic activity in different matrices. Chemosphere 61(2):259-266.
23. Ma L. 2009. Endocrine disruptors in female reproductive tract development and carcinogenesis. Trends Endocrinol Metab 20(7):357-363.
24. Martinovic D, Denny JS, Schmieder PK, Ankley GT, Sorensen PW. 2008. Temporal variation in the estrogenicity of a sewage treatment plant effluent and its biological significance. Environ Sci Technol 42(9):3421-3427.
25. Meeker JD. 2012. Exposure to environmental endocrine disruptors and child development. Arch Pediatr Adolesc Med 166(10):952-958.
26. Menuet A, Pellegrini E, Anglade I, Blaise O, Laudet V, Kah O, et al. 2002. Molecular characterization of three estrogen receptor forms in zebrafish: binding characteristics, transactivation properties, and tissue distributions. Biol Reprod 66(6):1881-1892.
27. Metzger D, Ali S, Bornert JM, Chambon P. 1995. Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J Biol Chem 270(16):9535-9542.
28. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA. 2001. Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44(24):4230-4251.
29. Nasevicius A, Ekker SC. 2000. Effective targeted gene 'knockdown' in zebrafish. Nat Gen 26(2):216-220.
30. Notch EG, Mayer GD. 2011. Efficacy of pharmacological estrogen receptor antagonists in blocking activation of zebrafish estrogen receptors. Gen Comp Endocrinol 173(1):183-189.
31. Petit FG, Valotaire Y, Pakdel F. 2000. The analysis of chimeric human/rainbow trout estrogen receptors reveals amino acid residues outside of P-and D-boxes important for the transactivation function. Nucleic Acids Res 28(14):2634-2642.
32. Reif AG, Crawford JK, Loper CA, Proctor A, Manning R, Titler R. 2012. Occurrence of Pharmaceuticals, Hormones, and Organic Wastewater Compounds in Pennsylvania Waters, 2006-09. Scientific Investigations Report 2012-5106. Reston, VA:U.S. Geological Survey Available: http://pubs.usgs.gov/sir/2012/5106/pdf/sir2012-5106.pdf [accessed 19 February 2014].
33. Robertson JF. 2001. ICI 182,780 (Fulvestrant™)-the first oestrogen receptor down-regulator-current clinical data. Br J Cancer 85(suppl 2):11-14.
34. Routledge EJ, Sumpter JP. 1996. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ Toxicol Chem 15(3):241-248.
35. Sanseverino J, Gupta RK, Layton AC, Patterson SS, Ripp SA, Saidak L, et al. 2005. Use of Saccharomyces cerevisiae BLYES expressing bacterial bioluminescence for rapid, sensitive detection of estrogenic compounds. Appl Environ Microbiol 71(8):4455-4460.
36. Soto AM, Sonnenschein C. 2010. Environmental causes of cancer: endocrine disruptors as carcinogens. Nat Rev Endocrinol 6(7):363-370.
37. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, et al. 2000. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-α-selective agonists. J Med Chem 43(26):4934-4947.
38. Sun J, Huang YR, Harrington WR, Sheng S, Katzenellenbogen JA, Katzenellenbogen BS. 2002. Antagonists selective for estrogen receptor α. Endocrinology 143(3):941-947.
39. Walker C. 1999. Haploid screens and gamma-ray mutagenesis. Methods Cell Biol 60:43-70.
40. Warnes CA. 2008. Sex differences in congenital heart disease: Should a woman be more like a man? Circulation 118(1):3-5.